4528 — Ono Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- ¥1tn
- ¥900bn
- ¥447bn
- 98
- 73
- 29
- 80
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 71,468 | 100,419 | 104,975 | 116,969 | 164,289 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 76,285 | 76,834 | 84,269 | 99,788 | 114,396 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 194,617 | 225,222 | 247,642 | 281,266 | 345,101 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 108,870 | 114,628 | 113,866 | 112,131 | 108,420 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 655,056 | 673,444 | 745,428 | 739,203 | 882,437 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 83,150 | 91,329 | 93,733 | 65,926 | 122,929 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 97,706 | 110,960 | 111,295 | 83,297 | 140,569 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 557,350 | 562,484 | 634,133 | 655,906 | 741,868 |
Total Liabilities & Shareholders' Equity | 655,056 | 673,444 | 745,428 | 739,203 | 882,437 |
Total Common Shares Outstanding |